Michael Cohen to Moderate Panel at LSX World Congress USA

Michael Cohen, co-practice group leader of Brown Rudnick's Life Sciences Group and Emerging Growth Companies & Venture Capital Group, will serve as a moderator at the LSX World Congress USA, which will be held in Boston on September 16-17.

This conference brings together leaders in biotech, medtech and pharmatech sectors. Brown Rudnick is a conference sponsor.

Cohen's panel, "Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare," is part of the Biotech Leaders Keynote Plenary, and will be held on September 16 at 9:00 am.

The panel will explore how biopharma companies are responding to evolving challenges - from AI innovation to an increase in cell and gene therapies-and focuses on:

• The resurgence in dealmaking as companies attempt to replenish pipelines in anticipation of upcoming patent expirations.
• The rise of Chinese biopharma innovation and the greater global opportunity for deals and partnerships.
• How AI is reshaping drug discovery and clinical trials, as well as challenges in accessing high-quality data.
• Cell and gene therapy developments and the challenges in scaling and potential treatments.

Panelists include: Mary Schaheen, President, Prevail Partners; Bibhash Mukhopadhyay, CEO and Chief Investment Advisor, Sapient Biotech Investments and Miletus Biotechnology; and Geeta Vemuri, Founder and Managing Partner, Agent Capital.

Learn more here.